Clinical study of epilepsy drug may have been purely promotional

Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine.

Read the whole article on Physorg

More from Physorg